ABBOTT LABORATORIES acquires Bigfoot Biomedical, Inc.
Snapshot
ABBOTT LABORATORIES acquired Bigfoot Biomedical, Inc. in September 2023. Bigfoot Biomedical, Inc. is a Milpitas, California, USA-based Medical devices — diabetes care business.
- Acquirer
- ABBOTT LABORATORIES
- Target
- Bigfoot Biomedical, Inc.
- Value
- (not disclosed)
- Date
- September 2023
- Type
- full acquisition
- Status
- ready
The deal at a glance
About this deal
ABBOTT LABORATORIES acquired Bigfoot Biomedical, Inc., a transaction completed in September 2023.
Bigfoot Biomedical, Inc. operates in Medical devices — diabetes care, is based in Milpitas, California, USA. Bigfoot Biomedical develops connected insulin-management solutions, furthering Abbott's efforts to develop connected solutions for making diabetes management more personal and precise.
Furthers Abbott's efforts to develop connected solutions for making diabetes management more personal and precise.
Connected insulin-management technology that complements Abbott's FreeStyle Libre diabetes franchise. Integrated into Abbott's Diabetes Care business
No advisory firms have been disclosed for this transaction.